Hope Bancorp Stock Quote HOPE - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

12.96

Bid

13.00

Ask

13.33

Volume

1,858,227

12.925 Day's Range 13.59

8.155 52 Week Range 13.59

Market Cap

1.563B

Previous Close

13.52

Open

13.46

Last Trade

40400

12.96

(formt)

Last Trade Time

17:33:53

Financial Volume

$ 24,577,308

VWAP

13.2262

Average Volume (3m)

771,212

Shares Outstanding

120,614,770

Dividend Yield

4.32%

PE Ratio

11.72

Earnings Per Share (EPS)

1.11

Revenue

571.44M

Net Profit

133.67M

Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth... Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services and other banking services. Show more

Sector

National Commercial Banks - Non Islamic

Industry

National Commercial Banks - Non Islamic

Website

www.bbcnbank.com

Headquarters

Los Angeles, California, USA

Founded

1970

Hope Bancorp Inc is listed in the National Commercial Banks - Non Islamic sector of the NASDAQ with ticker HOPE. The last closing price for Hope Bancorp was $13.52. Over the last year, Hope Bancorp shares have traded in a share price range of $ 8.155 to $ 13.59.

Hope Bancorp currently has 120,614,770 shares outstanding. The market capitalization of Hope Bancorp is $1.63 billion. Hope Bancorp has a price to earnings ratio (PE ratio) of 11.72.

ABIONYX Pharma : Bilan semestriel du contrat de liquidité contracté avec la Société TP ICAP (Europe) SA

Regulatory News: Au titre du contrat de liquidité confié par la société ABIONYX Pharma (Paris:ABNX) à la Société TP ICAP (Europe) SA, à la date du 28 juin 2024, les moyens suivants figuraient au...

ABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital social

Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de...

ABIONYX Carries out Successfully a Capital Increase With Cancellation of Preferential Subscription Rights for the Benefit of a Category of Persons Through the Issue of Shares With Warrants for an Amount of c.€3.4 Million

c.€3.4 million by issuing shares with warrants Subscription price: €1.37 for one share with warrants 1 warrant gives entitlement to 1 share to be issued at a price of €3 Exercise period: 3 years...

ABIONYX Pharma announces unanimous approval of all resolutions put to the vote at its Combined General Meeting

Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s...

ABIONYX décide une augmentation de capital avec suppression du droit préférentiel de souscription au profit d’une catégorie de personnes par émission d’ABSA d’un montant d’environ 3,4M€

Montant d’environ 3,4 millions d'euros par émission d’actions assorties de bons de souscription d’actions (« ABSA ») Prix de souscription : 1,37 euro pour une ABSA 1 BSA donne droit à 1 action à...

ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis

Based on encouraging Phase 2a data and a productive pre-IND Type B meeting with U.S. Food and Drug Administration (FDA), ABIONYX Pharma intends to file an Investigational New Drug application...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.36	2.85714285714	12.6	13.59	12.48	1235279	13.1961511	CS
4	2.25	21.0084033613	10.71	13.59	10.295	905047	12.23080965	CS
12	2	18.2481751825	10.96	13.59	9.8	771212	11.11932933	CS
26	1.16	9.83050847458	11.8	13.59	9.8	728797	10.99562645	CS
52	2.06	18.8990825688	10.9	13.59	8.155	742139	10.53267167	CS
156	-0.545	-4.03554239171	13.505	17.68	7.4199	802403	12.24502647	CS
260	-1.65	-11.2936344969	14.61	17.68	7.0347	795728	11.96645669	CS

Symbol	Price	Vol.
IMNNImunon Inc	$ 2.60 (118.49%)	5.44M
JTAIJet AI Inc	$ 0.40 (33.82%)	7.94M
TTOOT2 Biosystems Inc	$ 5.70 (20.25%)	128.23k
ISPOInspirato Inc	$ 6.27 (19.66%)	1.35M
AISPAirship AI Holdings Inc	$ 4.20 (17.65%)	504.42k
QXOQXO Inc	$ 11.99 (-80.18%)	1.27M
SYMSymbotic Inc	$ 29.19 (-18.07%)	762.4k
NRSNNeuroSense Therapeutics Ltd	$ 0.641 (-16.86%)	1.62k
CLDXCelldex Therapeutics Inc	$ 35.95 (-14.38%)	89.23k
LIPOLipella Pharmaceuticals Inc	$ 0.775 (-13.81%)	1.09M
NVDANVIDIA Corporation	$ 111.65 (0.05%)	8.68M
TLRYTilray Brands Inc	$ 1.98 (8.49%)	8.68M
JTAIJet AI Inc	$ 0.40 (33.82%)	7.94M
OXLCOxford Lane Capital Corporation	$ 5.57 (0.18%)	7.49M
SPCBSuperCom Ltd	$ 0.2041 (7.42%)	5.7M

Symbol

Price

Vol.

NVDANVIDIA Corporation

$ 111.65

(0.05%)

8.68M

TLRYTilray Brands Inc

$ 1.98

(8.49%)

8.68M

JTAIJet AI Inc

$ 0.40

(33.82%)

7.94M

OXLCOxford Lane Capital Corporation

$ 5.57

(0.18%)

7.49M

SPCBSuperCom Ltd

$ 0.2041

(7.42%)

5.7M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Hope Bancorp Inc (HOPE)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Hope Bancorp Inc

HOPE Latest News

ABIONYX Pharma : Bilan semestriel du contrat de liquidité contracté avec la Société TP ICAP (Europe) SA

ABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital social

ABIONYX Carries out Successfully a Capital Increase With Cancellation of Preferential Subscription Rights for the Benefit of a Category of Persons Through the Issue of Shares With Warrants for an Amount of c.€3.4 Million

ABIONYX Pharma announces unanimous approval of all resolutions put to the vote at its Combined General Meeting

ABIONYX décide une augmentation de capital avec suppression du droit préférentiel de souscription au profit d’une catégorie de personnes par émission d’ABSA d’un montant d’environ 3,4M€

ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis

Form 8-K - Current report

Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share

Hope Bancorp Reports 2024 Second Quarter Financial Results

U.S. Index Futures Climb Pre-Market as Tech Earnings, Fed Meeting Loom

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Hope Bancorp to Report 2024 Second Quarter Financial Results on Monday, July 29, 2024

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Hope Bancorp Inc (HOPE) Quote

Hope Bancorp Inc (HOPE)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Hope Bancorp Inc

HOPE Latest News

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App